Martin Dahl
Corporate Officer/Principal en ANAPTYSBIO, INC. .
Perfil
Martin Dahl is currently working as a Senior Vice President-Research at AnaptysBio, Inc. Previously, he worked as the Global Head-Immunology Network at Takeda Pharmaceuticals U.S.A., Inc. Dr. Dahl completed his undergraduate degree at the University of California, Irvine and holds a doctorate degree from the University of Tokyo.
Cargos activos de Martin Dahl
| Empresas | Cargo | Inicio |
|---|---|---|
| ANAPTYSBIO, INC. | Corporate Officer/Principal | 01/01/2018 |
Antiguos cargos conocidos de Martin Dahl.
| Empresas | Cargo | Fin |
|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | - |
Formación de Martin Dahl.
| University of California, Irvine | Undergraduate Degree |
| University of Tokyo | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ANAPTYSBIO, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Martin Dahl
